Targeting sepsis through inflammation and oxidative metabolism

Area of Science:

• Critical care medicine
• Infectious diseases
• Immunology

Background:

• Sepsis and septic shock are severe, life-threatening conditions resulting from infection, characterized by a dysregulated immune response.
• Septic shock, the most severe form, leads to distributive shock and high mortality rates, posing a significant public health challenge.
• Despite advances in early identification and therapy, progress in reducing sepsis-related mortality is modest.

Purpose of the Study:

• To review novel therapeutic strategies for sepsis and septic shock management.
• To highlight emerging targets beyond traditional approaches.
• To address the limitations of current diagnostic and scoring tools.

Main Methods:

• Literature review focusing on recent advancements in sepsis therapeutics.
• Analysis of novel treatment concepts targeting specific pathophysiological pathways.
• Discussion of emerging targets including oxidative stress, cytokine modulation, and endothelial cell modulation.

Main Results:

• Current diagnostic tools and scoring systems (e.g., SOFA, qSOFA) lack specificity and sensitivity, complicating early and accurate sepsis identification.
• Novel therapeutic avenues are being explored to address the complex immune dysregulation in sepsis.
• Targeting oxidative stress, modulating cytokines, and protecting endothelial cells represent promising frontiers in sepsis treatment.

Conclusions:

• The development of reliable diagnostic tools is crucial for improving sepsis outcomes.
• Novel therapeutic approaches targeting key molecular pathways offer potential for more effective sepsis and septic shock management.
• Continued research into innovative treatments is essential to reduce the high mortality associated with sepsis and septic shock.